We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
Trial supply management for optimised inventory.
Professional study build and libraries tailored to you.
Data collection and monitoring made easy.
Biopharmaceutical firm Imara has started dosing patients in the Phase IIb Ardent clinical trial of IMR-687 to treat adults with sickle cell disease (SCD).